IMMU-11. CLINICAL UPDATES AND CORRELATIVE FINDINGS FROM THE FIRST PATIENT WITH DIPG TREATED WITH INTRACRANIAL CAR T CELLS
Nicholas A. Vitanza(Seattle Children's Hospital), Julie Park(University of California, Los Angeles), Rimas J. Orentas(Capital Caring), Ashley Wilson(Center for Infectious Disease Research), Catherine M. Albert(Seattle Children's Hospital), Francisco A. Perez(Seattle Children's Hospital), Michael E. Berens(Translational Genomics Research Institute), Wenjun Huang(Lishui Central Hospital), Rebecca Gardner(Seattle Children's Hospital), Juliane Gust(University of Washington), Navin Pinto(Seattle Children's Hospital), Michael C. Jensen(Seattle Children's Hospital)
Cited by 8
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k